GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Valuation Rank

Kenvue (FRA:J4D) Valuation Rank


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Kenvue Valuation Rank Related Terms

Thank you for viewing the detailed overview of Kenvue's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Kenvue Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (FRA:J4D) » Definitions » Valuation Rank
Comparable Companies
KMB CHD EL CLX CL HIMS COTY IPAR ELF NWL PG XPAR:OR LSE:ULVR BOM:500696 LSE:RKT XTER:HEN3 XTER:BEI TSE:4452 OSTO:ESSITY B TSE:8113
Traded in Other Exchanges
KVUE:USA J4D:Germany
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Website
https://www.kenvue.com
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.